| Melissa Bukovi, | |
|
2844 Traceland Dr, Tupelo, MS 38801-4200 | |
| (662) 680-3148 | |
| Not Available |
| Full Name | Melissa Bukovi |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2844 Traceland Dr, Tupelo, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427594340 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5961 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Bukovi, 2844 Traceland Dr, Po Box 3667, Tupelo, MS 38801-4200 Ph: (662) 680-3148 | Melissa Bukovi, 2844 Traceland Dr, Tupelo, MS 38801-4200 Ph: (662) 680-3148 |
News Archive
Irvine Scientific, a leader in Assisted Reproductive Technologies (ART) announced today that it has received CE mark for a full range of its media designed for ART: Complete P-1® Medium with DSS™, Blastocyst Freeze Media, Blastocyst Thaw Media, Embryo Freeze Media, Embryo Thaw Media, Complete Early Cleavage Medium® (ECM®) with DSS™ and Complete MultiBlast Medium® with DSS™, Sperm Washing Medium, Sperm Maintenance Medium w/ HSA, 7% PVP w/ HSA, 10% PVP w/ HSA.
Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center.
A new preprint assessed vaccine effectiveness in 8.8 million people in New York six months after vaccination.
A higher proportion of male than of female managers have negative attitudes toward depression, a University of Gothenburg study shows.
Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.
› Verified 5 days ago
Ashley Gwen Smith, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 960 Commonwealth Blvd, Tupelo, MS 38804 Phone: 662-260-3789 Fax: 662-260-3790 | |
Melissa M Chatham, MS CCC-SP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 960 Commonwealth Blvd, Tupelo, MS 38804 Phone: 662-260-3789 Fax: 662-260-3790 | |
Anna Archer, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1901 Briar Ridge Rd, Tupelo, MS 38804 Phone: 662-844-0675 | |
Mrs. Leah Davis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2273 S Eason Blvd, Tupelo, MS 38804 Phone: 662-842-2461 | |
Mrs. Cynthia Holloway Jourdan, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 830 S Gloster St, Tupelo, MS 38801 Phone: 662-377-7360 | |
Mrs. Elaina Valsamakis Baggett, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2273 S Eason Blvd, Tupelo, MS 38804 Phone: 662-842-2461 | |
Ms. Connie Linda Davis, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Shands Dr, Tupelo, MS 38804 Phone: 662-842-6033 |